Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review

Among the multiple uncertainties surrounding the novel coronavirus disease (COVID-19) pandemic, a research letter published in The Lancet implicated drugs that antagonize the renin-angiotensin-aldosterone system (RAAS) in an unfavorable prognosis of COVID-19. This report prompted investigations to i...

Full description

Bibliographic Details
Main Authors: Filipe Ferrari, Vítor Magnus Martins, Flávio Danni Fuchs, Ricardo Stein
Format: Article
Language:English
Published: Elsevier España 2021-04-01
Series:Clinics
Subjects:
Pandemic
Infection
SARS-CoV-2
Hypertension
Heart Failure
Online Access:http://www.scielo.br/pdf/clin/v76/1807-5932-clin-76-e2342.pdf

Internet

http://www.scielo.br/pdf/clin/v76/1807-5932-clin-76-e2342.pdf

Similar Items